CH624939A5 - - Google Patents
Download PDFInfo
- Publication number
- CH624939A5 CH624939A5 CH1161877A CH1161877A CH624939A5 CH 624939 A5 CH624939 A5 CH 624939A5 CH 1161877 A CH1161877 A CH 1161877A CH 1161877 A CH1161877 A CH 1161877A CH 624939 A5 CH624939 A5 CH 624939A5
- Authority
- CH
- Switzerland
- Prior art keywords
- lower alkyl
- methoxy
- trimethyl
- group
- octahydro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/08—Aza-anthracenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/26—Benzomorphans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US72537176A | 1976-09-22 | 1976-09-22 | |
US78574677A | 1977-04-08 | 1977-04-08 | |
US05/818,713 US4119628A (en) | 1976-09-22 | 1977-07-25 | Process for preparing hexahydro-11 (eq)-CH2 CH2 COR5 -2,6-methano-3-benzazocines |
DE19782811849 DE2811849A1 (de) | 1976-09-22 | 1978-03-17 | 2,6-methano-3-benzazocine, verfahren zu deren herstellung und arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
CH624939A5 true CH624939A5 (de) | 1981-08-31 |
Family
ID=27432292
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH81881A CH626882A5 (de) | 1976-09-22 | 1977-09-22 | |
CH1161877A CH624939A5 (de) | 1976-09-22 | 1977-09-22 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH81881A CH626882A5 (de) | 1976-09-22 | 1977-09-22 |
Country Status (10)
Country | Link |
---|---|
US (2) | US4119628A (de) |
JP (1) | JPS5340777A (de) |
BE (1) | BE858866A (de) |
CA (1) | CA1095905A (de) |
CH (2) | CH626882A5 (de) |
DE (1) | DE2742715A1 (de) |
FR (2) | FR2375216A1 (de) |
GB (1) | GB1551562A (de) |
LU (1) | LU78162A1 (de) |
NL (1) | NL187630C (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4255579A (en) * | 1974-05-20 | 1981-03-10 | Sterling Drug Inc. | 11-Substituted hexahydro-2,6-methano-3-benzazocines |
BE864950A (fr) * | 1976-09-22 | 1978-09-18 | Sterling Drug Inc | 2,6-methano-3-benzazocines |
EP0019056A1 (de) * | 1979-03-26 | 1980-11-26 | Sterling Drug Inc. | Verfahren zur Herstellung von 11-niedrig-Alkoxy- und niedrig-Alkylthio-3-oxo-niedrig-alkyl-hexahydro-2,6-methano-3-benzazocinen |
US4912114A (en) * | 1988-03-18 | 1990-03-27 | Sandoz Ltd. | Morphinan derivatives |
WO2014072809A2 (en) * | 2012-11-09 | 2014-05-15 | Purdue Pharma L.P. | Benzomorphan analogs and the use thereof |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932422A (en) * | 1974-05-20 | 1976-01-13 | Sterling Drug Inc. | 8-Methylene-3-azabicyclo[3.3.1]non-6-en-4-ones |
-
1977
- 1977-07-25 US US05/818,713 patent/US4119628A/en not_active Expired - Lifetime
- 1977-09-19 CA CA286,972A patent/CA1095905A/en not_active Expired
- 1977-09-19 GB GB38944/77A patent/GB1551562A/en not_active Expired
- 1977-09-20 BE BE1008388A patent/BE858866A/xx not_active IP Right Cessation
- 1977-09-20 NL NLAANVRAGE7710325,A patent/NL187630C/xx not_active IP Right Cessation
- 1977-09-22 JP JP11452077A patent/JPS5340777A/ja active Granted
- 1977-09-22 CH CH81881A patent/CH626882A5/fr not_active IP Right Cessation
- 1977-09-22 DE DE19772742715 patent/DE2742715A1/de active Granted
- 1977-09-22 CH CH1161877A patent/CH624939A5/fr not_active IP Right Cessation
- 1977-09-22 FR FR7728584A patent/FR2375216A1/fr active Granted
- 1977-09-22 LU LU78162A patent/LU78162A1/xx unknown
-
1978
- 1978-02-07 FR FR7803369A patent/FR2378768A1/fr active Granted
- 1978-02-16 US US05/878,308 patent/US4148794A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NL187630B (nl) | 1991-07-01 |
US4148794A (en) | 1979-04-10 |
FR2378768B1 (de) | 1981-05-29 |
BE858866A (fr) | 1978-03-20 |
AU2903077A (en) | 1979-03-29 |
NL187630C (nl) | 1991-12-02 |
DE2742715A1 (de) | 1978-03-23 |
CH626882A5 (de) | 1981-12-15 |
LU78162A1 (de) | 1978-06-01 |
FR2375216A1 (fr) | 1978-07-21 |
US4119628A (en) | 1978-10-10 |
CA1095905A (en) | 1981-02-17 |
NL7710325A (nl) | 1978-03-28 |
GB1551562A (en) | 1979-08-30 |
JPS5340777A (en) | 1978-04-13 |
FR2378768A1 (fr) | 1978-08-25 |
FR2375216B1 (de) | 1980-09-19 |
JPS6224424B2 (de) | 1987-05-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2637737B2 (ja) | 新規な薬剤 | |
EP0058146A1 (de) | 2-(4-(Diphenylmethyl)-1-piperazinyl)-essigsäure und ihre Amide, Verfahren zu ihrer Bereitung und pharmazeutische Zusammensetzungen | |
EP0042781B1 (de) | 1-(4- Chinolyl), 2- oder 3- (2- oder 3-piperidyl oder pyrrolidinyl)-Äthanon oder -Propanon, Verfahren zu seiner Herstellung und seine Anwendung als Arzneimittel | |
EP0205375A1 (de) | Chinolinamidderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
EP0242518A1 (de) | Cycloalkano[1,2-b]indol-sulfonamide | |
CA1306261C (fr) | 1,4-dihydropyridines, leur procede de preparation et leur application comme medicaments | |
EP0031753B1 (de) | 2-(4-Piperidyl)-1-(4-chinolyl)-ethanon-Derivate, Zwischenprodukte und Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel | |
FR2561647A1 (fr) | Derives de 1-(hydroxymethyl)-1,6,7,11b-tetrahydro-2h,4h-(1,3)-oxazino- ou -thiazino(4,3,a)isoquinoleine, procede pour leur preparation et compositions pharmaceutiques les contenant | |
US4140698A (en) | 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles | |
EP0025192A2 (de) | Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel | |
EP0148167B1 (de) | Quinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Mittel | |
CH624939A5 (de) | ||
EP0053964B1 (de) | 1(4-Chinolyl)äthanol- bzw. -propanolderivate, diese enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
FR2471381A1 (fr) | Derives de l'ergoline, procede pour les preparer et leur emploi comme medicaments | |
CH635573A5 (en) | Process for preparing novel 1,2-dihydroxypropane derivatives | |
EP0048705A1 (de) | 2-(4-(Diphenylmethylen)-1-piperidinyl)essigsäuren und ihre Amide, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
EP0155518B1 (de) | S(-)-Celiprolol, dessen pharmazeutisch verträgliche Salze, Verfahren zu deren Herstellung und pharmazeutische Zubereitung | |
BE854655A (fr) | 9-hydroxyhexahydrobenzo (c) quinoleines et intermediaires de synthese | |
CH626881A5 (en) | Process for the preparation of new octahydrobenzo[c]quinolines | |
EP0038731B1 (de) | Thiazolderivate, ihre Herstellung und ihre therapeutische Anwendung | |
EP0384843A2 (de) | 1-Arylsulfonyl-2-piperidinon-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Verwendung als Arzneimittel und sie enthaltende Zusammensetzungen | |
US4843080A (en) | 1,12-disubstituted octahydroindolo[2,3-]quinolizine derivatives, pharmaceutical compositions | |
EP0001585A1 (de) | Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen | |
EP0003359B1 (de) | Spezifische optische Isomeren von 2-Aminoäthyl-1,4-benzodioxanen, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate enthaltend diese Verbindungen | |
HU193786B (en) | Process for producing dihydropyridine derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |